{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028898","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-06-16T20:30:35+00:00","discovered_at":"2026-06-16T20:32:00.305297+00:00","generated_at":"2026-06-16T20:32:37.814268+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intelligent Bio Solutions begins interference study for FDA 510(k) clearance of fingerprint drug test for codeine","bullets":["Interference Study with 75 healthy adults to validate the system's codeine specificity against everyday substances.","Expected completion by mid-July 2026; results will be part of the FDA 510(k) submission package.","Study runs concurrently with Method Comparison Study; follows January 2026 Cut-off Study.","Partners again with CenExel Clinical Research to conduct the clinical trial."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028898","json":"https://secwatch.observer/filing/0001493152-26-028898.json","markdown":"https://secwatch.observer/filing/0001493152-26-028898.md","text":"https://secwatch.observer/filing/0001493152-26-028898.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226028898/0001493152-26-028898-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226028898/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T20:32:37.814268+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}